X0306 4 2013-03-01 1 0001138400 BIOMIMETIC THERAPEUTICS, INC. BMTI 0001281239 PAPASAN LARRY W C/O BIOMIMETIC THERAPEUTICS, INC. 389 NICHOL MILL LANE FRANKLIN TN 37067 1 0 0 0 Common Stock 2013-03-01 4 M 0 18736 5.80 A 49517 D Common Stock 2013-03-01 4 M 0 20000 2.63 A 69517 D Common Stock 2013-03-01 4 D 0 69517 D 0 D Stock Options (right to buy) 5.80 2013-03-01 4 M 0 18376 0.00 D 2021-06-14 Common Stock 18736 0 D Stock Options (right to buy) 2.63 2013-03-01 4 M 0 20000 0.00 D 2022-06-11 Common Stock 20000 0 D Stock Options (right to buy) 17.09 2013-03-01 4 D 0 5831 D 2017-06-21 Common Stock 5831 0 D Stock Options (right to buy) 11.64 2013-03-01 4 D 0 8840 D 2018-06-19 Common Stock 8840 0 D Stock Options (right to buy) 9.95 2013-03-01 4 D 0 10653 D 2019-06-18 Common Stock 10653 0 D Stock Options (right to buy) 12.66 2013-03-01 4 D 0 8538 D 2020-06-17 Common Stock 8538 0 D Disposed of pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of November 19, 2012, by and among the Company, Wright Medical Group, Inc. ("Wright"), Achilles Merger Subsidiary, Inc. and Achilles Acquisition Subsidiary, LLC in exchange for the following merger consideration per share of the Company's common stock: (a) $1.50 in cash, without interest; (b) 0.2482 of a share of Wright's common stock; and (c) one contingent value right ("CVR") issued by Wright. Option exercised. Pursuant to the Merger Agreement, this stock option was conditionally vested to 100% subject to exercise upon the merger transaction. The reporting person received merger consideration described in footnote (1) above. Option canceled. Pursuant to the Merger Agreement, the reporting person entered into an agreement with the issuer to terminate stock options with an exercise price greater than $13.00. Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,613 shares of Wright common stock at an exercise price of $22.31 per share. Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 5,559 shares of Wright common stock at an exercise price of $19.07 per share. Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,455 shares of Wright common stock at an exercise price of $24.26 per share. /s/ Ginger Owens Smith, Attorney-in-Fact for Larry W. Papasan 2013-03-05